Search for a Cure
Coverage of the 2015 International AIDS Society Conference
- Details
- Category: HIV Treatment
- Published on Monday, 06 July 2015 00:00
- Written by HIVandHepatitis.com
HIVandHepatitis.com coverage of the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), July 19-22, in Vancouver, Canada.
Conference highlights include HIV treatment as prevention, pre-exposure prophylaxis (PrEP), new antiretroviral therapies, HIV cure research, hepatitis C and HIV/HCV coinfection, and global scale-up of prevention and treatment.
7/22/15
BHIVA 2015: Many People with HIV Willing to Take Part in Cure Research Despite its Risks
- Details
- Category: Search for a Cure
- Published on Thursday, 23 April 2015 00:00
- Written by Roger Pebody
There is a strong interest among people living with HIV in research towards an HIV cure, with many potential participants willing to consider antiretroviral treatment interruption. Respondents to a survey presented at the British HIV Association (BHIVA) conference this week in Brighton generally understood that they would be unlikely to benefit personally from cure research. Priorities for a cure were to eliminate health problems and the risk of HIV transmission, rather than necessarily testing HIV-negative.
Trial of CCR5-Deleted Stem Cell Gene Therapy for HIV Gets FDA Go-Ahead
- Details
- Category: Search for a Cure
- Published on Wednesday, 25 March 2015 00:00
- Written by CIRM
The U.S. Food and Drug Administration (FDA) has given approval to proceed with a clinical trial of a gene therapy method that cuts the gene for the CCR5 coreceptor out of stem cells, making them resistant to HIV entry, the California Institute for Regenerative Medicine (CIRM) recently announced.
Long-time Researcher Discusses Myths About HIV Pathogenesis, Treatment, and Cure
- Details
- Category: Search for a Cure
- Published on Friday, 17 April 2015 00:00
- Written by Cell Press
Over the 3 decades of the epidemic a number of misconceptions have arisen about HIV infection, how the immune system fights the virus, and how best to treat and potentially cure it, along with a number of important questions that remain unanswered, according to an opinion article in the April 13 advance edition of Trends in Molecular Medicine by Jay Levy from the University of California at San Francisco, one of the first researchers to study HIV. The trend toward earlier antiretroviral therapy and treatment-as-prevention are among the issues he contests.
CROI 2015: Experimental Agents Reverse HIV Latency, Help Immune System Fight Infected Cells
- Details
- Category: Search for a Cure
- Published on Friday, 20 March 2015 00:00
- Written by Liz Highleyman
Researchers at the recent 2015 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle presented data on several experimental agents that may play a role in achieving a "functional cure" for HIV, or prolonged remission without disease progression. These include drugs that reactivate the latent HIV reservoir, interfere with expression of viral DNA, and help the immune system target HIV-infected cells.